# FDA Inspection 1029902 - Continental Vitamin Company Inc - October 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/1b82f06f-4f88-4a27-bb4a-a685c330ff15
Source feed: FDA_Inspections

> FDA Inspection 1029902 for Continental Vitamin Company Inc on October 26, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029902
- Company Name: Continental Vitamin Company Inc
- Inspection Date: 2017-10-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1166241 - 2022-03-30](https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/8c4241e4-a96d-44a4-b959-8cbe67060d55)
- [FDA Inspection 1056101 - 2018-04-30](https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/6a6e58cd-0053-4b84-957a-d94870a1e807)
- [FDA Inspection 829858 - 2013-04-02](https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/1b3161af-592f-4369-8352-3939ea04a9f3)

Company: https://www.keypedia.com/companies/continental-vitamin-company-inc/4083f968-af68-4de9-9ca8-5522baaa9446

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c